Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen ...

Adding Imfinzi (durvalumab) to Bacillus Calmette-Guérin (BCG) therapy helped patients with high-risk, non-muscle invasive ...

Victoria, British Columbia, Canada, October 17, 2025. Teuton Resources Corp. (“Teuton” or “the Company”) (“TUO”-TSX-V) ("TFE" ...

Atezolizumab shows no significant benefit over BCG alone in treating high-risk non-muscle invasive bladder cancer, according to the ALBAN trial results.

Durvalumab addition to BCG therapy significantly improved DFS in BCG-naive, high-risk NMIBC patients, achieving a 32% reduction in DFS event risk. The combination therapy was well-tolerated, with ...

MAI-listed JSP Pharmaceutical Manufacturing (Thailand), a leading distributor of medicines and nutritional supplements, is moving swiftly to capitalise on the surging popularity of the "Janey Live" ...

Learn more about whether Kanzhun Limited or Innodata Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) ('ExGen”, the 'Company”) and MTB Metals Corp. (TSXV: MTB, OTCQB: MBYMF, ...

The Cincinnati Bengals have been without Joe Burrow for more than four games due to a Grade 3 turf toe injury that required ...

To view our latest e-Edition click the image on the left. To view our latest e-Edition click the image on the left.